Arcadia Biosciences, Inc. (RKDA) › Shareholders' EquityArcadia Biosciences, Inc. (RKDA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $8.01M2018: $12.81M2019: $8.32M2020: $28.55M2021: $31.20M2022: $20.90M2023: $12.70M2024: $6.22M2025: $4.14M$4.14M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.14M-33.5%2024$6.22M-51.0%2023$12.70M-39.2%2022$20.90M-33.0%2021$31.20M+9.3%2020$28.55M+243.0%2019$8.32M-35.0%2018$12.81M+60.0%2017$8.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share